<code id='E3B1E47BDE'></code><style id='E3B1E47BDE'></style>
    • <acronym id='E3B1E47BDE'></acronym>
      <center id='E3B1E47BDE'><center id='E3B1E47BDE'><tfoot id='E3B1E47BDE'></tfoot></center><abbr id='E3B1E47BDE'><dir id='E3B1E47BDE'><tfoot id='E3B1E47BDE'></tfoot><noframes id='E3B1E47BDE'>

    • <optgroup id='E3B1E47BDE'><strike id='E3B1E47BDE'><sup id='E3B1E47BDE'></sup></strike><code id='E3B1E47BDE'></code></optgroup>
        1. <b id='E3B1E47BDE'><label id='E3B1E47BDE'><select id='E3B1E47BDE'><dt id='E3B1E47BDE'><span id='E3B1E47BDE'></span></dt></select></label></b><u id='E3B1E47BDE'></u>
          <i id='E3B1E47BDE'><strike id='E3B1E47BDE'><tt id='E3B1E47BDE'><pre id='E3B1E47BDE'></pre></tt></strike></i>

          entertainment

          entertainment

          author:Wikipedia    Page View:2255
          A dosage of Wegovy, a drug used for weight loss
          Amanda Andrade-Rhoades/AP

          U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

          The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

          advertisement

          The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          knowledge

          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more
          Burning questions about Delta and the next phase of the Covid pandemic
          Burning questions about Delta and the next phase of the Covid pandemic

          IzzyGalvan,20,wearsafacemaskwhilevisitingtheGriffithObservatoryoverlookingdowntownLosAngelesthisweek

          read more
          George Santos makes 1st court appearance after pleading not guilty to 13 counts
          George Santos makes 1st court appearance after pleading not guilty to 13 counts

          1:57GeorgeSantosarrivesatfederalcourtJune30,2023,inCentralIslip,N.Y.JohnMinchillo/APRep.GeorgeSantos

          read more

          Updated Covid vaccine has 54% effectiveness, new study suggests

          AhealthcareworkerfillsasyringewithPfizer'sCovid-19vaccine.LynneSladky/APNewdatareleasedThursdaybythe